BetterLife Pharma Inc. announced that it has appointed Mr. Henri Sant-Cassia, co-founder of The Conscious Fund, to its Board of Directors. Mr. Sant-Cassia has 10 years of experience working in the plant medicine field and has been a serial entrepreneur since his early twenties. Since 2018, he has been a founding partner at The Conscious Fund, the most active venture fund in the psychedelic medicine space. His expertise includes psychedelic compounds, operating models, venture funding, growth and exit planning, as well as managing media and investor relations campaigns. His work has created over $200 million in company valuations within the psychedelic world, and he previously worked in the manufacturing, retail and research of cannabinoid-based products. The company announced the resignation of Mr. Sergei Stetsenko from its Board of Directors.